M06.29 Rheumatoid bursitis, multiple sites

Name of the Condition

• Rheumatoid bursitis, multiple sites

Summary

Rheumatoid bursitis, multiple sites, is an inflammatory condition affecting multiple bursae (fluid-filled sacs that cushion joints) in individuals with rheumatoid arthritis (RA). It results from chronic autoimmune inflammation, leading to bursal swelling, pain, and functional impairment. The condition requires differentiation from other bursal disorders and is part of the broader spectrum of RA-related musculoskeletal manifestations.

Causes

Rheumatoid bursitis, multiple sites, arises from the autoimmune processes underlying rheumatoid arthritis, where the immune system targets synovial tissues, including bursae. Chronic inflammation, immune complex deposition, and cytokine-mediated damage contribute to bursal irritation and fluid accumulation. It may occur in joints already affected by RA or as a widespread manifestation in predisposed areas.

Risk Factors

• Pre-existing rheumatoid arthritis, particularly with active joint inflammation.
• Mechanical stress or repetitive motion at multiple bursal sites.
• Age, with onset typically in middle to older adulthood.
• Female gender, reflecting RA’s higher prevalence in women.
• Systemic inflammation or active RA flares, increasing widespread bursal involvement.

Symptoms

• Localized swelling, warmth, and tenderness over multiple affected bursae.
• Pain with movement or pressure on inflamed areas.
• Reduced range of motion in adjacent joints.
• Warmth or redness (if inflammation is acute).
• Functional impairment due to widespread joint involvement.

Diagnosis

Diagnosis involves correlating clinical findings with a history of rheumatoid arthritis or serologic evidence of RA. Physical examination reveals tenderness, swelling, and limited mobility at multiple bursal sites. Imaging (e.g., ultrasound or MRI) may confirm bursal inflammation, while laboratory tests (e.g., rheumatoid factor, anti-CCP antibodies) support RA diagnosis. Exclusion of other causes (e.g., infection, trauma) is essential.

Treatment Options

Treatment focuses on managing RA and reducing bursal inflammation. Options include:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids for pain and swelling.
• Disease-modifying antirheumatic drugs (DMARDs) to control underlying RA.
• Physical therapy to maintain joint function and reduce stress.
• Intra-bursal corticosteroid injections for localized relief.
• Rest and activity modification to avoid exacerbating inflammation.

Prognosis and Follow-Up

Prognosis depends on RA control and early intervention. With proper treatment, symptoms often improve, but recurrent flares may occur. Regular follow-up with a rheumatologist is recommended to monitor RA activity and adjust therapy. Long-term management aims to prevent joint damage and maintain function.

Complications

• Chronic pain and functional impairment.
• Bursal infection (rare, but possible with prolonged inflammation).
• Joint stiffness or deformity from untreated inflammation.
• Reduced quality of life due to widespread symptoms.

Lifestyle & Prevention

• Manage RA with prescribed medications to reduce systemic inflammation.
• Avoid repetitive motions or excessive pressure on bursal sites.
• Use ergonomic supports or padding to minimize stress.
• Maintain a healthy weight to reduce joint load.
• Engage in low-impact exercises (e.g., swimming) to preserve mobility.

When to Seek Professional Help

Seek care if symptoms worsen, new sites become affected, or fever/ redness suggests infection. Prompt evaluation is needed for severe pain, sudden swelling, or inability to move joints, as these may indicate complications requiring urgent treatment.

Tips for Medical Coders

Document the number of affected bursal sites and confirm a diagnosis of rheumatoid arthritis (RA) to support coding. Ensure clinical correlation with RA history or serologic evidence, as isolated bursitis without RA would not qualify for this code. Note the involvement of multiple sites to distinguish from single-site or unspecified bursitis codes.